CLINICAL_TRIALS
withdrawal
· 2021-10-20
Clinical Trial Update: 99m Tc-ANNexin-V-128 Scintigraphy for the Identification of Complicated Carotid Atherosclerotic Plaques [Phase 2, Phase 3]
Summary
Clinical trial for 99m Tc-ANNexin-V-128 scintigraphy in identifying complicated carotid atherosclerotic plaques has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Carotid Atherosclerosis, Atherosclerotic Plaque | Phase 2, Phase 3 | Status: WITHDRAWN